Founding Story Purple 1920x1080 Aspect Ratio 1200 384

Founding Story

The beginnings of Vor Bio’s approach

Our founding science was developed by the research team lead by Dr. Siddhartha Mukherjee, MD, DPhil.

Dr. Siddhartha Mukherjee and his team published the proof-of-concept study for our lead program in the Proceedings of the National Academy of Sciences.

A word from our founder

Today, working seamlessly across departments and encouraging the free flow of ideas, leading HSC biologists, genome engineers, cancer immunologists, manufacturing experts, clinicians, and others make up a passionate team striving to collaboratively develop a novel approach to cancer treatment, one of medicine’s greatest challenges.

The Latest from the Vor Bio Blog

Fellowship in Action: Our First In-House Manufacturing Run

Earlier this year, Vor Bio dosed its first patient with VCAR33ALLO, a transplant donor-derived CAR-T targeting CD33 in AML patients. VCAR33ALLO is manufactured at our in-house facility in Cambridge, MA, and Voracians were directly involved in every part of the process. We spoke ...

Confronting Imposter Syndrome & Empowering the AAPI Community: Reflections from Dr. Robert Ang

Who has entered a meeting room full of people and thought “I feel like a total fraud and I don’t belong here?” Me. All the time. As an Asian American, I've navigated a lifelong journey shadowed by the weight of imposter syndrome—a phenomenon I've come to understand is all too familiar among individuals of Asian American and Pacific Islander (AAPI) heritage.

A Generous Gift: My Transplant Journey

By Darren Johnson, Medical Science Liaison

It all started with a blood draw. I was 17 and in the middle of my senior year of high school and my doctor was checking some routine labs. I thought nothing of it as I was a healthy young ...

Our Approach

Vor Bio’s unique approach aims to protect the healthy cells, expose the cancer.